Editorial on the Research TopicChallenges for the provision of guideline-recommended cancer care to rural and medically underserved communities
Health disparities have persisted in cancer care despite extensive research and a decades-long mandate to eliminate them (). Many leading research and policy organizations have specifically identified rural cancer disparities as one of the important priorities for public health and social justice (–). While a number of international studies have identified factors contributing to the disparities in cancer care and proposing programs and demonstrations to address the problem, only a few healthcare organizations in a hand-full of countries have been able to successfully implement and scale up such programs (–).
The topic objective is to reveal some of the hidden underlying causes of unequal access to cancer care and develop tailored interventions and strategies to mitigate these barriers. In essence, the topic bridges across the disciplinary fields of health services research, dissemination & implementation science, health equity, policy, economics and behavioral research and includes diverse issues such as health insurance, workforce shortages, financial toxicity (FT), patient preferences and inequities in health care access. The gap between what is known to optimize healthcare delivery and what is actually implemented in everyday practice remains one of the most important issues hindering the healthcare systems and public health around the world. Finding ways to enhance access and awareness of patients, providers and healthcare organizations (dissemination) and to facilitate adoption and integration of best evidence into practice (implementation) are essential to improving health care and health outcomes in underserved communities.
Healthcare organizations and agencies in the public and private sectors spend billions of dollars on research and service delivery programs each year, yet patients and stakeholders often lack sufficient information to make decisions regarding the most effective treatment strategies for their particular condition that is available to them locally. One of the key reasons why evidence-based interventions often do not deliver the expected benefits in community settings is implementation failure (–). Restricted staffing, technology, financing and lack of strategic leadership in community oncology clinics pose significant challenges for adaptation, implementation and dissemination of evidence-based practices in such settings (–).
Dissemination, implementation, and sustainment of best practices and evidence-based interventions require supportive infrastructures and coordination among various levels of healthcare system, spanning from regional care systems to individual point of care (Figure 1).
Figure 1
The studies in this series provided insight into the complexity of implementation barriers and strategies to facilitate it at various levels of healthcare systems. They also addressed the complexity of implementation at various stages of implementation journey, spanning from pre-implementation planning to post-implementation evaluation.
Crabtree-Ide et al. assessed barriers to implement guideline-concordant cancer services in rural communities, at pre-implementation stage, and proposed potential implementation strategies to improve implementation at regional level. Team-based cancer care delivery and development of regional networks were identified as the most pressing strategies. While multidisciplinary cancer care teams have become a norm at large academic cancer centers, rural and small free-standing community oncology clinics rarely possess the resources and personnel to form multidisciplinary teams within and across the regions they serve (Crabtree-Ide et al.).
Lack of capacity (time, expertise and reimbursement) among community oncology clinics and rural hospitals to offer guideline-recommended cancer interventions has been identified as the main barrier to successful implementation of skills training in community settings, where more than 80% of US adult cancer patients receive care (
Lack of patient transportation is one of the most common logistical barriers to cancer screening and access of cancer supportive services. While the solutions to this problem, like rideshares, are wide available, their integration with healthcare system is not without challenges as demonstrated by Bell-Brown et al. Scheduling non-emergency medical transportation (NEMT) services requires infrastructure and coordination at various levels. One important requirement is a Health Insurance Portability and Accountability Act (HIPAA) compliant platform, that would allow to bill the costs of transportation directly to health insurance organization, and ensures safety of patients after sedation (e.g., endoscopy).
Wahlen et al. presented the first study that pro-actively and systematically planned for evidence-based adaption of a successful regional cancer care network for the needs and capacity of rural hospitals. To address the complexities of implementation, they distilled the intervention into its core functions that could be optimized and assessed in future interventional studies.
Individuals historically underserved by medical institutions (e.g., patients living in rural areas, non-English speaking patients, patients of color) experience disproportionate financial burden and poor access to cancer care (
These studies exemplify the value of integrating dissemination and implementation lens into various levels of intervention development and assessment, as framed by the Designing for Dissemination, Implementation and Sustainability (D4DIS) models (
Statements
Author contributions
The authors jointly developed the ideas, wrote and edited the editorial. All authors contributed to the article and approved the submitted version.
Conflict of interest
The author KN receives research funding from Pharmavite LLC and Roche Diagnostics. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
ChenS-LWangS-CHoC-JKaoY-LHsiehT-YChenW-Jet alProstate cancer mortality-to-incidence ratios are associated with cancer care disparities in 35 countries. Sci Rep. (2017) 7(1):40003. 10.1038/srep40003
2.
AhmedSShahidRK. Disparity in cancer care: a Canadian perspective. Curr Oncol. (2012) 19(6):376–82. 10.3747/co.19.1177
3.
FoxPBoyceA. Cancer health inequality persists in regional and remote Australia. Med J Aust. (2014) 201(8):445–6. 10.5694/mja14.01217
4.
WeaverSJBlakeKDVanderpoolRCGardnerBCroyleRTSrinivasanS. Advancing rural cancer control research: national cancer institute efforts to identify gaps and opportunities. Cancer Epidemiol Biomarkers Prev. (2020) 29(8):1515–8. 10.1158/1055-9965.EPI-20-0453
5.
AroraSKalishmanSDionDSomDThorntonKBankhurstAet alPartnering urban academic medical centers and rural primary care clinicians to provide complex chronic disease care. Health Aff. (2011) 30(6):1176–84. 10.1377/hlthaff.2011.0278
6.
McCulloughLEFlowersCR. Identifying and addressing disparities in survival outcomes for rural patients with cancer. JAMA Network Open. (2018) 1(4):e181243. 10.1001/jamanetworkopen.2018.1243
7.
UngerJMMoseleyASymingtonBChavez-MacGregorMRamseySDHershmanDL. Geographic distribution and survival outcomes for rural patients with cancer treated in clinical trials. JAMA Netw Open. (2018) 1(4):e181235. 10.1001/jamanetworkopen.2018.1235
8.
UngerJMMoseleyABCheungCKOsarogiagbonRUSymingtonBRamseySDet alPersistent disparity: socioeconomic deprivation and cancer outcomes in patients treated in clinical trials. J Clin Oncol. (2021) 39(12):1339–48. 10.1200/JCO.20.02602
9.
BullCTeedeHWatsonDCallanderEJ. Selecting and implementing patient-reported outcome and experience measures to assess health system performance. JAMA Health Forum. (2022) 3(4):e220326. 10.1001/jamahealthforum.2022.0326
10.
DopsonSLocockLGabbayJFerlieEFitzgeraldL. Evidence-based medicine and the implementation gap. Health. (2003) 7(3):311–30. 10.1177/1363459303007003004
11.
GrolR. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care. (2001) 39(8 Suppl 2):Ii46–54. 10.1097/00005650-200108002-00003
12.
MeitMHamlinBNPiyaBEttaroL. Financing rural public health activities in prevention and health promotion. NORC walsh center for rural health analysis (2008).
13.
MeitMHernandezN. Establishing and maintaining public health infrastructure in rural communities final report. NORC walsh center for rural health analysis (2012).
14.
RickettsTC. The changing nature of rural health care. Annu Rev Public Health. (2000) 21(1):639–57. 10.1146/annurev.publhealth.21.1.639
15.
NoyesKMonsonJRRizviISavastanoAGreenJSSevdalisN. Regional multiteam systems in cancer care delivery. J Oncol Pract. (2016) 12(11):1059–66. 10.1200/JOP.2016.013896
16.
Centers for Disease Control and Prevention. Cancer data and statistics (2021). Available at:https://www.cdc.gov/cancer/dcpc/data/index.htm.
17.
National Cancer Institute. NCI-designated cancer centers (2019). Available at:https://www.cancer.gov/research/infrastructure/cancer-centers.
18.
WolinKYColditzGAProctorEK. Maximizing benefits for effective cancer survivorship programming: defining a dissemination and implementation plan. Oncologist. (2011) 16(8):1189–96. 10.1634/theoncologist.2011-0054
19.
KwanBMBrownsonRCGlasgowREMorratoEHLukeDA. Designing for dissemination and sustainability to promote equitable impacts on health. Annu Rev Public Health. (2022) 43(1):331–53. 10.1146/annurev-publhealth-052220-112457
20.
BrownsonRCColditzGAProctorEK. Dissemination and implementation research in health: Translating science to practice. 2nd ed. New York, NY: Oxford University Press (2018).
21.
BrownsonRCJacobsJATabakRGHoehnerCMStamatakisKA. Designing for dissemination among public health researchers: findings from a national survey in the United States. Am J Public Health. (2013) 103(9):1693–9. 10.2105/AJPH.2012.301165
22.
GlasgowREEmmonsKM. How can we increase translation of research into practice? Types of evidence needed. Annu Rev Public Health. (2007) 28:413–33. 10.1146/annurev.publhealth.28.021406.144145
23.
FriedmanCRubinJBrownJBuntinMCornMEtheredgeLet alToward a science of learning systems: a research agenda for the high-functioning learning health system. J Am Med Inform Assoc. (2015) 22(1):43–50. 10.1136/amiajnl-2014-002977
Summary
Keywords
cancer care, barriers to care, implementation, disparities (health), financial toxicities, sustainability
Citation
Yousefi Nooraie R and Noyes K (2023) Editorial: Challenges for the provision of guideline-recommended cancer care to rural and medically underserved communities. Front. Health Serv. 2:1113916. doi: 10.3389/frhs.2022.1113916
Received
01 December 2022
Accepted
15 December 2022
Published
10 January 2023
Volume
2 - 2022
Edited and reviewed by
Nick Sevdalis, King's College London, United Kingdom
Updates

Check for updates
Copyright
© 2023 Yousefi Nooraie and Noyes.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Katia Noyes enoyes@buffalo.edu
Specialty Section: This article was submitted to Implementation Science, a section of the journal Frontiers in Health Services
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.